Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres
Journal Article
·
· Journal of Medicinal Chemistry
more »
- Department of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- INDUSTRY
- OSTI ID:
- 1497118
- Journal Information:
- Journal of Medicinal Chemistry, Vol. 57, Issue 7; ISSN 0022-2623
- Publisher:
- American Chemical Society (ACS)
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53—MDM2 protein-protein interaction
Modulating solvation interactions of deep eutectic solvents formed by ammonium salts and carboxylic acids through varying the molar ratio of hydrogen bond donor and acceptor
Optimization beyond AMG 232: Discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein–protein interaction
Journal Article
·
Thu Mar 15 00:00:00 EDT 2018
· Russian Chemical Bulletin
·
OSTI ID:1497118
+2 more
Modulating solvation interactions of deep eutectic solvents formed by ammonium salts and carboxylic acids through varying the molar ratio of hydrogen bond donor and acceptor
Journal Article
·
Thu Feb 18 00:00:00 EST 2021
· Journal of Chromatography
·
OSTI ID:1497118
Optimization beyond AMG 232: Discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein–protein interaction
Journal Article
·
Fri Aug 01 00:00:00 EDT 2014
· Bioorganic and Medicinal Chemistry Letters
·
OSTI ID:1497118
+17 more